SNCA and Parkinson disease: While CSF samples demonstrated lower levels of α-synuclein in PD patients in comparison with the control group, its corresponding concentration in serum and saliva samples was not significantly different between PD patients (saliva, 65.6 ± 42.1 pg/mL) and healthy individuals (saliva, 64.4 ± 60.7 pg/mL).